Studies of murine models showed that Dnmt3a mutations impart a differentiation block and increased self-renewal on HSC11–13, drive HSC clonal expansion in the presence of inflammation14,15, promote AML development and impart resistance to anthracyclines16,17. The gene discussed is DNMT3A; the disease is acute myeloid leukemia.